Stock Information
Akebia Therapeutics Inc (AKBA)
Ticker Symbol: AKBA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $308.06 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -0.0771
Revenue (TTM): $0.87 M
Dividend Yield: N/A%
ROE: -62.72%
Latest News
-
Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts
Thu, May 28, 2026 9:18 AM
Key Financials
Financial data not available